CClinicalTrials.gg
Active, not recruitingNCT06266650PMEOMTUpdated Dec 3, 2024

Unilateral vs Bilateral Application of Muscle Energy Techniques in Pelvic Somatic Dysfunction

An interventional study of Osteopathic Treatment Technique- Muscle Energy Treatment in Pelvic Somatic Dysfunction, sponsored by The Touro College and University System. Active, not recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2024-12-03.

Sponsored by The Touro College and University System · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 1 month ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Sex
All
01

Study summary

The goal of this clinical trial is to compare the efficacy of pelvic muscle energy technique online against the traditional full length osteopathic pelvic treatment protocol. The main question it aims to answer are

  • Can one single pelvic muscle energy technique can correct all pelvic somatic dysfunctions (SD)?

Participants will

  • be positioned by the physician into the area of treatment into a position of resistance, which is the restrictive barrier.
  • be instructed to use the targeted muscles for 3-5 seconds in the direction of ease while the physician provides a counterforce.
  • be instructed to stop contracting their muscles and evaluate the area for decreased tension, then repositions the patient into their new restrictive barrier.
  • These steps are repeated three to five times and then the dysfunction is reevaluated.

Subjects diagnosed with pelvic SD will be divided into two groups. One group will be treated with traditional one and be compared with the pelvic muscle energy group.

Read the detailed description

Osteopathic muscle energy technique (MET) is a well-known modality widely used by osteopathic practitioners. MET can be applied to different regions and segments of the body, is well tolerated and effective in reducing muscle hypertonicity and pain sensation. MET involves a patient actively using their muscles on request from a precisely controlled position, in a specific direction, against a distinctly executed counter force. The group of pelvic MET consists of specific variations directed to particular somatic dysfunction (SD) of innominate and pubic bones, such as pelvic shears, pelvic outflares and pelvic inflares. All techniques are well known and widely used. Based on empirical clinical observations, not confirmed by any research, it was suggested that pubic abduction/adduction SD MET combination should be able to correct all pelvic SD including innominate SD.

The investigators intend to assess if application of abduction/adduction SD combination MET may resolve any one-sided diagnosed pelvic SD.

MET involves a patient actively using their muscles on request from a precisely controlled position, in a specific direction, against a distinctly executed counter force. During MET, the physician positions the area of treatment into a position of resistance, which is the restrictive barrier. The physician then instructs the patient to use the targeted muscles for 3-5 seconds in the direction of ease while the physician provides a counterforce. The physician then tells the patient to stop contracting their muscles and evaluate the area for decreased tension, then repositions the patient into their new restrictive barrier. These steps are repeated three to five times and then the dysfunction is reevaluated.

Subjects diagnosed with pelvic SD will be divided into two groups. The control group will be treated with traditional one-sided MET, the second group will be treated with combination MET. Results of post-treatment exams will be collected and statistically analyzed.

02

Conditions studied

  • Pelvic Somatic Dysfunction
03

In context

Lead sponsor

The Touro College and University System is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Current osteopathic medical students first-and second year.

Exclusion criteria

Exclusion criteria:

  • Acute severe pelvic pain,
  • Pregnancy,
  • History of pelvic trauma or surgery,
  • Receiving osteopathic treatment for pelvic dysfunction outside this study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Pelvic Muscle Energy - One sided

    Receives pubic abduction/adduction somatic dysfunction combinations one sided

    Other: Osteopathic Treatment Technique- Muscle Energy Treatment

  • Active comparator
    Pelvic Muscle Energy - two sided

    Receives pubic abduction/adduction somatic dysfunction combinations two sided

    Other: Osteopathic Treatment Technique- Muscle Energy Treatment

Interventions

  • OtherOsteopathic Treatment Technique- Muscle Energy Treatment

    Muscle Energy Treatment involves a patient actively using their muscles on request from a precisely controlled position, in a specific direction, against a distinctly executed counter force. During Muscle Energy Treatment, the physician positions the area of treatment into a position of resistance, which is the restrictive barrier. The physician then instructs the patient to use the targeted muscles for 3-5 seconds in the direction of ease while the physician provides a counterforce. The physician then tells the patient to stop contracting their muscles and evaluate the area for decreased tension, then repositions the patient into their new restrictive barrier. These steps are repeated three to five times and then the dysfunction is reevaluated.

06

What researchers measure

Primary outcomes

  1. Resolution of pelvic somatic dysfunction

    Restoration of anatomical landmarks symmetry Tested using forward flexion test - Standing upright subject bends forward and motion in sacroiliac joint is evaluated. The side where the investigator's thumb moves farthest is the restricted side. This side will be treated with muscle energry. Resolution will show symmetry between the sacroiliac joints.

    Time frame: Through treatment completion, on average 30 minutes

Secondary outcomes

  1. Anterior anatomical landmarks assessment

    Anterior superior iliac spine symmetry or asymmetry

    Time frame: 5 minutes

  2. Posterior anatomical landmarks assessment

    Posterior superior iliac spine symmetry or asymmetry

    Time frame: 5 minutes

07

Study locations

1 site
  • Touro College of Osteopathic Medicine
    Harlem, New York 10027, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06266650
Lead sponsor
The Touro College and University System
Responsible party
Mikhail Volokitin, MD, DO. (Principal Investigator, The Touro College and University System) — Principal investigator
First posted
Feb 20, 2024
Start date
Oct 30, 2024
Primary completion
Aug 30, 2025 (estimated)
Completion
Sep 30, 2025 (estimated)
Last update
Dec 3, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion